ANXA6 and pancreatic ductal adenocarcinoma: In pancreatic ductal adenocarcinoma (PDA) cells in vitro, loss of ANXA6 in CAF altered the development of ANXA6, LRP1, and TSP1 complexes, suppressing PDA and metastasis (31).